Apatinib as a salvage treatment for refractory metastatic colorectal cancer.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.3556
Abstract: 3556Background: Apatinib, an oral VEGFR2 inhibitor, has been approved as third line treatment for metastatic gastric cancer in China. The aim of this study was to evaluate the efficacy and safety o... read more here.
Keywords: salvage treatment; treatment; treatment refractory; apatinib salvage ... See more keywords